TipRanks
Sarepta Therapeutics (DE:AB3A)
FRANKFURT:AB3A
Germany Market
AB3A
Sarepta Therapeutics
RESEARCH TOOLSreports

Sarepta Therapeutics (AB3A) Balance Sheet

6 Followers

Sarepta Therapeutics Balance Sheet

Sarepta Therapeutics's total assets for Q2 2026 were $3.19B, an increase of 0.30% from the previous quarter. DE:AB3A total liabilities were $1.66B for the fiscal quarter, a -0.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 3.35B$ 3.96B$ 3.26B$ 3.13B$ 3.15B
Total Liabilities
$ 2.21B$ 2.44B$ 2.41B$ 2.74B$ 2.22B
Total Equity Gross Minority
$ 1.14B$ 1.53B$ 859.34M$ 384.95M$ 928.01M
Other Metrics
Currency in USD

Sarepta Therapeutics Debt to Assets